2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine

C145H178F2N36O8S — CID 159569568

IUPAC2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine
SMILESCC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3F)nn2)CC(C)(C)N1.CC1CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)N1.CC1CC(Oc2ccc(-c3ccc(-n4cccn4)cc3O)nn2)CC(C)N1.CN(c1ccc(-c2ccc(O)cc2F)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2ccc3nn(C)cc3c2)nn1)C1CC(C)(C)NC(C)(C)C1.Cn1cc(-c2csc(-c3ccc(OC4CC(C)(C)NC(C)(C)C4)nn3)c2)cn1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2CC3(CCNCC3)C2)nn1
InChIInChI=1S/C22H26FN5O.C22H30N6.C21H27N5OS.C20H27FN4O.C20H22N6O.2C20H23N5O2/c1-21(2)10-16(11-22(3,4)28-21)29-20-8-7-19(26-27-20)17-6-5-14(9-18(17)23)15-12-24-25-13-15;1-21(2)12-17(13-22(3,4)26-21)28(6)20-10-9-18(23-24-20)15-7-8-19-16(11-15)14-27(5)25-19;1-20(2)9-16(10-21(3,4)25-20)27-19-7-6-17(23-24-19)18-8-14(13-28-18)15-11-22-26(5)12-15;1-19(2)11-13(12-20(3,4)24-19)25(5)18-9-8-17(22-23-18)15-7-6-14(26)10-16(15)21;27-18-9-14(15-10-22-23-11-15)1-2-16(18)17-3-4-19(25-24-17)26-12-20(13-26)5-7-21-8-6-20;1-13-10-16(11-14(2)22-13)27-20-7-6-18(23-24-20)17-5-4-15(12-19(17)26)25-9-3-8-21-25;1-12-7-16(8-13(2)23-12)27-20-6-5-18(24-25-20)17-4-3-14(9-19(17)26)15-10-21-22-11-15/h5-9,12-13,16,28H,10-11H2,1-4H3,(H,24,25);7-11,14,17,26H,12-13H2,1-6H3;6-8,11-13,16,25H,9-10H2,1-5H3;6-10,13,24,26H,11-12H2,1-5H3;1-4,9-11,21,27H,5-8,12-13H2,(H,22,23);3-9,12-14,16,22,26H,10-11H2,1-2H3;3-6,9-13,16,23,26H,7-8H2,1-2H3,(H,21,22)
InChIKeyMHQJDOGRBLONAX-UHFFFAOYSA-N
MW2623.33 g/mol
LogP24.68
Rot. Bonds25

About 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine

2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine (PubChem CID 159569568) has the molecular formula C145H178F2N36O8S and a molecular weight of 2623.33 g/mol. Its IUPAC name is 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine.

Molecular Properties

Compound Name2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine
PubChem CID159569568
Molecular FormulaC145H178F2N36O8S
Molecular Weight2623.33 g/mol
Exact Mass2621.43
IUPAC Name2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine
SMILESCC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3F)nn2)CC(C)(C)N1.CC1CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)N1.CC1CC(Oc2ccc(-c3ccc(-n4cccn4)cc3O)nn2)CC(C)N1.CN(c1ccc(-c2ccc(O)cc2F)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2ccc3nn(C)cc3c2)nn1)C1CC(C)(C)NC(C)(C)C1.Cn1cc(-c2csc(-c3ccc(OC4CC(C)(C)NC(C)(C)C4)nn3)c2)cn1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2CC3(CCNCC3)C2)nn1
InChIInChI=1S/C22H26FN5O.C22H30N6.C21H27N5OS.C20H27FN4O.C20H22N6O.2C20H23N5O2/c1-21(2)10-16(11-22(3,4)28-21)29-20-8-7-19(26-27-20)17-6-5-14(9-18(17)23)15-12-24-25-13-15;1-21(2)12-17(13-22(3,4)26-21)28(6)20-10-9-18(23-24-20)15-7-8-19-16(11-15)14-27(5)25-19;1-20(2)9-16(10-21(3,4)25-20)27-19-7-6-17(23-24-19)18-8-14(13-28-18)15-11-22-26(5)12-15;1-19(2)11-13(12-20(3,4)24-19)25(5)18-9-8-17(22-23-18)15-7-6-14(26)10-16(15)21;27-18-9-14(15-10-22-23-11-15)1-2-16(18)17-3-4-19(25-24-17)26-12-20(13-26)5-7-21-8-6-20;1-13-10-16(11-14(2)22-13)27-20-7-6-18(23-24-20)17-5-4-15(12-19(17)26)25-9-3-8-21-25;1-12-7-16(8-13(2)23-12)27-20-6-5-18(24-25-20)17-4-3-14(9-19(17)26)15-10-21-22-11-15/h5-9,12-13,16,28H,10-11H2,1-4H3,(H,24,25);7-11,14,17,26H,12-13H2,1-6H3;6-8,11-13,16,25H,9-10H2,1-5H3;6-10,13,24,26H,11-12H2,1-5H3;1-4,9-11,21,27H,5-8,12-13H2,(H,22,23);3-9,12-14,16,22,26H,10-11H2,1-2H3;3-6,9-13,16,23,26H,7-8H2,1-2H3,(H,21,22)
InChIKeyMHQJDOGRBLONAX-UHFFFAOYSA-N
XLogP24.68
TPSA531.73 Ų
H-Bond Donors14
H-Bond Acceptors42
Rotatable Bonds25
Heavy Atoms192
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002623.33
LogP ≤ 524.68
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1042

Analyze 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?
The IUPAC name of 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine (CID 159569568) is 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine.
What is the SMILES notation for 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?
The canonical SMILES for 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine is CC1(C)CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3F)nn2)CC(C)(C)N1.CC1CC(Oc2ccc(-c3ccc(-c4cn[nH]c4)cc3O)nn2)CC(C)N1.CC1CC(Oc2ccc(-c3ccc(-n4cccn4)cc3O)nn2)CC(C)N1.CN(c1ccc(-c2ccc(O)cc2F)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2ccc3nn(C)cc3c2)nn1)C1CC(C)(C)NC(C)(C)C1.Cn1cc(-c2csc(-c3ccc(OC4CC(C)(C)NC(C)(C)C4)nn3)c2)cn1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2CC3(CCNCC3)C2)nn1.
What is the InChIKey of 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?
The InChIKey is MHQJDOGRBLONAX-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26FN5O.C22H30N6.C21H27N5OS.C20H27FN4O.C20H22N6O.2C20H23N5O2/c1-21(2)10-16(11-22(3,4)28-21)29-20-8-7-19(26-27-20)17-6-5-14(9-18(17)23)15-12-24-25-13-15;1-21(2)12-17(13-22(3,4)26-21)28(6)20-10-9-18(23-24-20)15-7-8-19-16(11-15)14-27(5)25-19;1-20(2)9-16(10-21(3,4)25-20)27-19-7-6-17(23-24-19)18-8-14(13-28-18)15-11-22-26(5)12-15;1-19(2)11-13(12-20(3,4)24-19)25(5)18-9-8-17(22-23-18)15-7-6-14(26)10-16(15)21;27-18-9-14(15-10-22-23-11-15)1-2-16(18)17-3-4-19(25-24-17)26-12-20(13-26)5-7-21-8-6-20;1-13-10-16(11-14(2)22-13)27-20-7-6-18(23-24-20)17-5-4-15(12-19(17)26)25-9-3-8-21-25;1-12-7-16(8-13(2)23-12)27-20-6-5-18(24-25-20)17-4-3-14(9-19(17)26)15-10-21-22-11-15/h5-9,12-13,16,28H,10-11H2,1-4H3,(H,24,25);7-11,14,17,26H,12-13H2,1-6H3;6-8,11-13,16,25H,9-10H2,1-5H3;6-10,13,24,26H,11-12H2,1-5H3;1-4,9-11,21,27H,5-8,12-13H2,(H,22,23);3-9,12-14,16,22,26H,10-11H2,1-2H3;3-6,9-13,16,23,26H,7-8H2,1-2H3,(H,21,22).
What are the key properties of 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine?
2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine has a molecular weight of 2623.33 g/mol, XLogP of 24.68, 25 rotatable bonds, 14 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-(2,7-diazaspiro[3.5]nonan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-pyrazol-1-ylphenol;2-[6-(2,6-dimethylpiperidin-4-yl)oxypyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-fluoro-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]phenol;3-[2-fluoro-4-(1H-pyrazol-4-yl)phenyl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine;N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)pyridazin-3-amine;3-[4-(1-methylpyrazol-4-yl)thiophen-2-yl]-6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazine is sourced from PubChem (CID 159569568), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).